Certara accelerates medicines using biosimulation software and technology-enabled services to transform traditional drug discovery and development. Our clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.
Certara Insight is the new name of our European regulatory arm following the combination of Insight Medical Writing, AUTHOR!, and Synchrogenix. We assure sponsor regulatory success with our talented medical writers and submissions leaders in the UK, Germany, and the Netherlands.
We are known for our accuracy, consistency and clarity. Our clients rely on our flexible and highly qualified team to deliver mission critical projects on time and budget, enabled by cutting edge Certara regulatory technology.